Development of methods of male contraception: impact of the World Health Organization Task Force (Q35172636)

6 August 2017

1 reference

title

Development of methods of male contraception: impact of the World Health Organization Task Force (English)

1 reference

World Health Organization

6 August 2017

0 references

1 reference

Geoffrey M H Waites

1

1 reference

PubMed ID

12849793

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

6 August 2017

Fertility and Sterility

1 reference

6 August 2017

80

1 reference

6 August 2017

1

1 reference

6 August 2017

1-15

1 reference

A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Editorial: hormonal male contraception--lessons from the East when the Western market fails

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

World Health Organization. Special programme of research, development and research training in human reproduction. The first fifteen years: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

The in vitro sperm penetration test: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Reversible antifertility action of testosterone propionate in human males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Vasectomy and health: cardiovascular and other diseases following vasectomy in Sichuan province, People's Republic of China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Vasectomy and risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Studies of the mechanism of action of gossypol as a male antifertility agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Contraceptive efficacy of testosterone-induced azoospermia in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies. World Health Organization Task force on Methods for The Regulations of Male Fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

The effects of exogenous testosterone on sexuality and mood of normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Familial prostatic cancer risk and low testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900577-6

10.1016/S0015-0282(03)00577-6

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849793